Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

about

Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia.

P2860

Q43186595-4292FB7E-0DEC-4696-9DEB-CD11E45B35E1

P2860

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

Item

http://www.wikidata.org/entity/Q39280604

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

@en

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

@nl

type

Item

label

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

@en

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

@nl

prefLabel

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

@en

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

@nl

P1476

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

@en

P2093

L Labeaga

http://www.w3.org/2001/XMLSchema#string

M K Church

http://www.w3.org/2001/XMLSchema#string

P2860

Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria

H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study

One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases

P-Glycoprotein, a gatekeeper in the blood-brain barrier.

In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.

Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.

Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.

P31

scholarly article

P356

10.1111/JDV.14305

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28467671

http://www.w3.org/2001/XMLSchema#string

P921

histamine antagonist

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

about

P2860

P2860

Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921